Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2013-04-10 | New | $6,000,000 | $6,000,000 | Equity Only | 06 | SEC link |
| 2012-07-13 | New | $6,000,000 | $6,000,000 | Equity Only | 06 | SEC link |
| 2011-09-23 | New | $6,000,000 | $6,000,000 | Equity Only | 06 | SEC link |
| 2010-05-25 | New | $7,999,999 | $7,999,999 | Equity Only | 06 | SEC link |
| 2010-04-09 | New | $1,000,000 | $1,000,000 | Equity and Debt | 06 | SEC link |
| 2008-11-26 | Paper Filing | Unknown | Unknown | Other | Not Available |
| Name | Role |
|---|---|
| Michael Carusi | Director |
| Andrew Cragg | Director |
| Andrew Cragg, M.D. | Director |
| Jeani Delagardelle | Director |
| Bruce Feuchter | Executive |
| G Ray Martin | Director, Executive |
| G. Ray Martin, Ph.D. | Director, Executive |
| David Milne | Director |
| George Wallace | Director |